Literature DB >> 30268837

Regulation of lymphocyte trafficking in central nervous system autoimmunity.

Mohamed Oukka1, Estelle Bettelli2.   

Abstract

CD4+ T helper (Th) cells play a central role in orchestrating protective immunity but also in autoimmunity. Multiple Sclerosis (MS) is a human autoimmune disease of the central nervous system (CNS) characterized by the infiltration of inflammatory lymphocytes and myeloid cells into the brain and spinal cord, leading to demyelination, axonal damage, and progressive loss of motor functions. The release of T cells in the circulation and their migration in the central nervous system are key and tightly regulated processes which have been targeted to decrease CD4+ T cell presence in the CNS and limit disease progression. Here, we review two of these pathways and discuss how their blockade modulate different subsets of CD4+ T cells.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30268837      PMCID: PMC6286213          DOI: 10.1016/j.coi.2018.09.008

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  64 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

Review 2.  Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.

Authors:  Jason G Cyster; Susan R Schwab
Journal:  Annu Rev Immunol       Date:  2011-12-05       Impact factor: 28.527

3.  Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Authors:  Ingunn M Stromnes; Lauren M Cerretti; Denny Liggitt; Robert A Harris; Joan M Goverman
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

Review 4.  Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis.

Authors:  Chang Wook Lee; Ji Woong Choi; Jerold Chun
Journal:  Arch Pharm Res       Date:  2010-10-30       Impact factor: 4.946

5.  Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model.

Authors:  Hye Jung Kim; Veronique E Miron; Danuta Dukala; Richard L Proia; Samuel K Ludwin; Maria Traka; Jack P Antel; Betty Soliven
Journal:  FASEB J       Date:  2011-01-19       Impact factor: 5.191

6.  Finding a way out: lymphocyte egress from lymphoid organs.

Authors:  Susan R Schwab; Jason G Cyster
Journal:  Nat Immunol       Date:  2007-12       Impact factor: 25.606

Review 7.  FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.

Authors:  Volker Brinkmann
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

8.  Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells.

Authors:  Monica Montes; Xin Zhang; Laureline Berthelot; David-Axel Laplaud; Sophie Brouard; Jianping Jin; Sarah Rogan; Diane Armao; Valerie Jewells; Jean-Paul Soulillou; Silva Markovic-Plese
Journal:  Clin Immunol       Date:  2008-11-05       Impact factor: 3.969

9.  Effects of natalizumab treatment on Foxp3+ T regulatory cells.

Authors:  Max-Philipp Stenner; Anne Waschbisch; Dorothea Buck; Sebastian Doerck; Hermann Einsele; Klaus V Toyka; Heinz Wiendl
Journal:  PLoS One       Date:  2008-10-06       Impact factor: 3.240

10.  Fingolimod modulates peripheral effector and regulatory T cells in MS patients.

Authors:  Laura D Serpero; Gilberto Filaci; Alessia Parodi; Florinda Battaglia; Francesca Kalli; Davide Brogi; Giovanni Luigi Mancardi; Antonio Uccelli; Daniela Fenoglio
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-07       Impact factor: 4.147

View more
  4 in total

Review 1.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble.

Authors:  Eléonore Beurel; Marisa Toups; Charles B Nemeroff
Journal:  Neuron       Date:  2020-06-17       Impact factor: 17.173

Review 2.  Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders.

Authors:  Ellen Doney; Alice Cadoret; Laurence Dion-Albert; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2021-05-17       Impact factor: 3.698

3.  A TLR/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis.

Authors:  Maria Tredicine; Chiara Camponeschi; Davide Pirolli; Matteo Lucchini; Mariagrazia Valentini; Maria Concetta Geloso; Massimiliano Mirabella; Marco Fidaleo; Benedetta Righino; Camilla Moliterni; Ezio Giorda; Mario Rende; Maria Cristina De Rosa; Maria Foti; Gabriela Constantin; Francesco Ria; Gabriele Di Sante
Journal:  iScience       Date:  2022-01-11

4.  Central Nervous System Barriers Impact Distribution and Expression of iNOS and Arginase-1 in Infiltrating Macrophages During Neuroinflammation.

Authors:  Daniela C Ivan; Sabrina Walthert; Giuseppe Locatelli
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.